Cyclo Therapeutics (NASDAQ:CYTH – Get Free Report) is projected to issue its quarterly earnings data before the market opens on Monday, March 17th. Analysts expect the company to announce earnings of ($0.17) per share and revenue of $0.32 million for the quarter.
Cyclo Therapeutics Stock Performance
CYTH opened at $0.70 on Friday. Cyclo Therapeutics has a 52-week low of $0.55 and a 52-week high of $1.79. The firm has a market cap of $23.04 million, a P/E ratio of -0.78 and a beta of -0.57. The business’s fifty day moving average is $0.79 and its 200-day moving average is $0.73.
About Cyclo Therapeutics
Featured Stories
- Five stocks we like better than Cyclo Therapeutics
- Stock Market Sectors: What Are They and How Many Are There?
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- Upcoming IPO Stock Lockup Period, Explained
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- EV Stocks and How to Profit from Them
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Cyclo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyclo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.